Renaissance Technologies - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M407. A total of 27 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q4 2019$166,000
-31.1%
736,572
+53.0%
0.00%
Q3 2019$241,000
-25.6%
481,354
+10.0%
0.00%
Q2 2019$324,000
-45.2%
437,582
+14.8%
0.00%
-100.0%
Q1 2019$591,000
+8.0%
381,082
+5.2%
0.00%0.0%
Q4 2018$547,000
+14.4%
362,282
+53.1%
0.00%
Q3 2018$478,000
+126.5%
236,672
+90.3%
0.00%
Q2 2018$211,000124,3720.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q1 2019
NameSharesValueWeighting ↓
CVI Holdings, LLC 156,655$266,0000.33%
Stonepine Capital Management, LLC 77,900$132,0000.08%
Anson Funds Management LP 54,450$93,0000.06%
SABBY MANAGEMENT, LLC 169,661$288,0000.04%
IMS Capital Management 24,916$42,0000.03%
Paulson Wealth Management Inc. 11,250$4,0000.00%
WEDBUSH SECURITIES INC 16,250$28,0000.00%
PEDDOCK CAPITAL ADVISORS, LLC 1$00.00%
UBS Group AG 1,813$3,0000.00%
MARINO, STRAM & ASSOCIATES LLC 2$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders